KaloBios Pharma (Nasdaq: KBIO) shares are down around 9 percent following news that it received a delisting notice from the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE